Table 2.
Baseline characteristics for all patients entering the main study and extension phase
| Characteristic | Main study n = 366 | Extension phase n = 211 |
|---|---|---|
| Sex, n (%) | ||
| Female | 115 (31.4) | 57 (27.0) |
| Male | 251 (68.6) | 154 (73.0) |
| Ethnic origin, n (%) | ||
| Caucasian | 307 (83.9) | 183 (86.7) |
| Black | 4 (1.1) | 4 (1.9) |
| Hispanic | 5 (1.4) | 4 (1.9) |
| Asian | 12 (3.3) | 4 (1.9) |
| Other | 2 (0.5) | 1 (0.5) |
| Missinga | 36 (9.8) | 15 (7.1) |
| Age and height, mean (SD) [range] | ||
| Age (years) | 59.5 (13.81) [24–85] | 57.9 (14.53) [27–85] |
| Weight (kg) | 73.1 (15.47) [33–128] | 74.1 (11.53) [33–128] |
aLocal legislation prevented study centres in France from recording ethnic or racial information.